US biotech drugs to grow
15 Jan 2000
Demand for biotechnology drugs in the US is set to grow by some 13 per cent per year, with the market reaching $15.9billion by 2002, according to market researchers at the Freedonia Group. The largest segment, blood-related agents, will reach $5.5billion.
